RBC Capital lowered the firm’s price target on Nutrien to $80 from $85 but keeps an Outperform rating on the shares. The company delivered a “solid” Q3 that “hit all the right notes” – potash improvement, Retail margin recovery, and further capex discipline, the analyst tells investors in a research note. Nutrien shares also look undervalued, implying a 1- to 2-turn EV to expected EBITDA multiple discount relative to peers on the fertilizer business, the firm added.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NTR: